Getinge AB (publ)
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage so… Read more
Market Cap & Net Worth: Getinge AB (publ) (GTN0)
Getinge AB (publ) (F:GTN0) has a market capitalization of $4.41 Billion (€4.30 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #3856 globally and #378 in its home market, demonstrating a -3.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Getinge AB (publ)'s stock price €16.90 by its total outstanding shares 254152373 (254.15 Million).
Getinge AB (publ) Market Cap History: 2026 to 2026
Getinge AB (publ)'s market capitalization history from 2026 to 2026. Data shows growth from $4.41 Billion to $4.41 Billion (0.00% CAGR).
Getinge AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Getinge AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GTN0 by Market Capitalization
Companies near Getinge AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Getinge AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Getinge AB (publ) Historical Marketcap From 2026 to 2026
Between 2026 and today, Getinge AB (publ)'s market cap moved from $4.41 Billion to $ 4.41 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €4.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Getinge AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.41 Billion USD |
| MoneyControl | $4.41 Billion USD |
| MarketWatch | $4.41 Billion USD |
| marketcap.company | $4.41 Billion USD |
| Reuters | $4.41 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.